From: Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis
 | Controls | IPF | RA-ILD | P- value |
---|---|---|---|---|
N | 10 | 58 | 26 | Â |
PADI2 (MIN-MAX) | 3,67E-03 (7.7E-04 – 9.6E-03) | 1.1E-03 (2.6E-05 – 1.7E-02) | 3.7E-04 (9.7E-05 – 2.4E-02) | C vs IPF p = 0.02* C vs RA p = 0.001 IPF vs RA p = 0.02 |
PADI4 (MIN-MAX) | 5.52 E-07 (0–4.7E-05) | 6.01E-06 (0–1.4E-04) | 1.57E-05 (0–7.0E-05) | C vs IPF p = 0.019* C vs RA p = 0.0053 IPF vs RA ns |
N-smokers | 10 | 36 | 14 | Â |
PADI2 (MIN-MAX) | 3,67E-03 (7.7E-04 – 9.6E-03) | 1.1E-03 (2.5E-05 – 1.6E-02) | 3.9E-04 1.3E-04 – 2.4E-02) | C vs IPF vs RA-ILD ns** |
PADI4 (MIN-MAX) | 5.52 E-07 (0–4.7E-05) | 9.4E-06 (0–1.4E-04) | 2.1E-05 (2.8E-06– 7 E-05) | C vs IPF p = 0.019* C vs RA p = 0.0032 IPF vs RA ns |